Eleftha 375 mg Injection
$169.88
$138.60
Eleftha 375 mg injection is an effective treatment option for patients battling metastatic breast cancer and metastatic gastric cancer, harnessing the power of a monoclonal antibody to combat these aggressive forms of cancer. By specifically targeting the HER2/neu receptor, Eleftha works to inhibit the growth and reproduction of cancerous tumor cells, thereby slowing disease progression and improving patient outcomes. This targeted approach not only enhances the efficacy of treatment but also minimizes damage to surrounding healthy tissues. While Eleftha 375 mg can provide significant therapeutic benefits, it may also lead to some common side effects, such as fatigue and nausea, which should be monitored closely. Patients should be aware of potential severe allergic reactions and inform their healthcare provider of any pre-existing conditions before starting treatment. As with any cancer therapy, a thorough discussion with a healthcare professional is essential to understand the benefits and risks associated with Eleftha. This innovative injection represents a crucial advancement in oncology, offering hope to those facing challenging diagnoses. With its targeted mechanism of action, Eleftha 375 mg injection stands as a vital tool in the fight against certain types of metastatic cancers.
Quantity
Active Pharmaceutical Ingredient
Uses
• Eleftha 375 mg injection is primarily used to treat specific infections caused by susceptible bacteria. This medication works by inhibiting bacterial growth, allowing the immune system to effectively combat the infection. It is typically administered in a hospital setting under the supervision of healthcare professionals to ensure proper dosing and monitoring. Patients receiving Eleftha 375 mg injection may experience a rapid improvement in their symptoms as the treatment takes effect.
• In cases of severe bacterial infections where oral antibiotics are not viable, Eleftha 375 mg injection serves as a crucial alternative. This intravenous formulation allows for immediate delivery of the medication into the bloodstream, facilitating a quicker response. Healthcare providers often choose Eleftha 375 mg injection for patients who require urgent treatment. The effectiveness of this injection can be pivotal in managing acute infections.
• Eleftha 375 mg injection may also be indicated for patients undergoing surgical procedures who are at risk of developing infections. Administering this medication prior to surgery can help reduce the likelihood of postoperative complications. The use of Eleftha 375 mg injection in this context underscores the importance of infection control in surgical settings. By providing prophylactic coverage, it aids in maintaining patient safety and enhancing recovery outcomes.
• For patients with compromised immune systems, Eleftha 375 mg injection can be an essential part of their treatment regimen. Such patients are often more susceptible to infections, making timely intervention critical. The administration of Eleftha 375 mg injection helps to address these vulnerabilities effectively. Healthcare teams may rely on this medication to provide targeted support in managing infection risks for these individuals.
Benefits
Breast cancer: Eleftha 375 mg Injection is used for the treatment of breast cancer when there has been no significant improvement with other medicines. It helps stop the growth and spread of the cancer and relieves symptoms of breast cancer, such as lumps in the breast, nipple discharge, or changes in the shape or texture of the breast. A doctor or nurse will give this medicine by injection. To get the most benefit, follow your doctor's instructions carefully.
Stomach cancer: Stomach cancer, also known as gastric cancer, can occur in the inner lining (called the lining) of the stomach or in the walls of the stomach. There are different types of stomach cancer depending on where it starts, the area affected and the severity of the cancer. Eleftha 375 mg helps kill cancer cells and stop them growing and spreading. To get the most benefit, follow your doctor's instructions carefully.
Side Effects
Like all medicines, Eleftha 375 mg Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Infection
• Fever
• Weight Loss
• Appetite Loss
• Skin Rashes
• Constipation
• Reduce in Blood Count
• Heartburn
• Runny Nose
• Hair Loss
• Muscle and Joint Pain
Common Side Effects
• congestive heart failure
• Lung problems
• trouble in breathing
• fluid in the lungs
How To Use
Eleftha Injection is an intravenous infusion, administered under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.
Safety Advice
• Alcohol: Drinking alcohol while taking Eleftha 375 Injection is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Eleftha Injection in patients with kidney disease. No dose adjustment of Eleftha 375 mg Injection is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Eleftha 375 Injection. Eleftha 375 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Eleftha 375 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Eleftha Injection is safe for use in patients with mild to moderate liver disease, no dose adjustment of Eleftha 375 mg Injection is recommended. The use of Eleftha 375 mg Injection is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Eleftha 375 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Eleftha Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Eleftha 375 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Eleftha 375 Injection.